MedKoo Cat#: 130030 | Name: Gemlapodect

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Gemlapodect is a phosphodiesterase 10A (PDE10A) inhibitor currently undergoing clinical trials for use as a treatment for Tourette's Syndrome by modulating the signaling of D2 receptors. PDE10A is highly expressed in striatal medium spiny neurons, with inhibition leading to behavioral and antipsychotic effects.

Chemical Structure

Gemlapodect
Gemlapodect
CAS#1380329-87-2

Theoretical Analysis

MedKoo Cat#: 130030

Name: Gemlapodect

CAS#: 1380329-87-2

Chemical Formula: C22H21N7O3

Exact Mass: 431.1706

Molecular Weight: 431.46

Elemental Analysis: C, 61.24; H, 4.91; N, 22.73; O, 11.12

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Gemlapodect
IUPAC/Chemical Name
1-methyl-4-[(morpholin-4-yl)carbonyl]-N-(2- phenyl[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-5- carboxamide
InChi Key
MMCSMWHWVGGCGL-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H21N7O3/c1-27-19(17(14-23-27)22(31)28-9-11-32-12-10-28)21(30)24-16-7-8-29-18(13-16)25-20(26-29)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,24,30)
SMILES Code
O=C(C1=C(C(N2CCOCC2)=O)C=NN1C)NC3=CC4=NC(C5=CC=CC=C5)=NN4C=C3
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 431.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Menniti FS, Chappie TA, Schmidt CJ. PDE10A Inhibitors-Clinical Failure or Window Into Antipsychotic Drug Action? Front Neurosci. 2021 Jan 20;14:600178. doi: 10.3389/fnins.2020.600178. PMID: 33551724; PMCID: PMC7855852.